FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4120811000001101: Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17971701000001114 Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17971801000001117 Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely ticlopidine hydrochloride 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Ticlopidine hydrochloride false Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Is a Ticlid true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Ticlopidine hydrochloride true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Is pack of False Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has AMP True Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start